Chemotherapy

​

Chemotherapy for Wilms tumor is one of the most important and commonly used treatments for childhood kidney cancer. Pediatric chemotherapy treatment uses specialized anti-cancer medications to destroy cancer cells, shrink tumors, reduce the risk of cancer spread, and help prevent Wilms tumor relapse. Chemotherapy plays a central role in many pediatric oncology treatment plans and is often combined with nephrectomy surgery, radiation therapy for Wilms tumor, and long-term survivorship care as part of a comprehensive childhood cancer treatment approach.

​

Treatment plans for Wilms tumor chemotherapy are carefully tailored to each child based on factors such as tumor stage, favorable or anaplastic histology, whether the cancer has spread beyond the kidney, and whether the disease is newly diagnosed, recurrent, or relapsed. Some children receive chemotherapy before nephrectomy surgery for Wilms tumor to shrink the tumor and make surgical removal safer, while others receive chemotherapy after surgery to destroy remaining microscopic cancer cells and reduce the risk of recurrence.

​

Children with stage 3 Wilms tumor, stage 4 Wilms tumor, bilateral Wilms tumor, or relapsed Wilms tumor may require more intensive pediatric chemotherapy protocols involving additional anti-cancer medications and longer treatment periods. In some high-risk cases, chemotherapy for relapsed Wilms tumor may also be combined with stem cell transplant, radiation therapy, or advanced pediatric relapse treatment strategies.

​

Although chemotherapy treatment for childhood kidney cancer can be physically and emotionally challenging, major advances in pediatric oncology have significantly improved survival outcomes for children diagnosed with Wilms tumor. Throughout treatment, pediatric oncology teams closely monitor children for side effects of chemotherapy, treatment response, infection risk, nutritional needs, and overall health while providing supportive care to help families navigate every stage of therapy, recovery, and long-term survivorship after Wilms tumor treatment.

Common Chemotherapy Drugs Used for Wilms Tumor​

Several chemotherapy drugs are commonly used to treat Wilms tumor in children, often in carefully planned combinations tailored to the child’s tumor stage, histology, and risk of relapse. Chemotherapy for pediatric kidney cancer works by destroying cancer cells, shrinking tumors, and reducing the likelihood of Wilms tumor recurrence as part of a comprehensive pediatric oncology treatment plan.

​

Standard chemotherapy protocols for Wilms tumor frequently include medications such as vincristine, dactinomycin, and doxorubicin. These anti-cancer drugs work in different ways to target and destroy cancer cells while helping improve long-term survival outcomes for children with Wilms tumor.

​

Children with stage 3 Wilms tumor, stage 4 Wilms tumor, bilateral Wilms tumor, or relapsed Wilms tumor may require more intensive pediatric chemotherapy regimens involving additional medications such as cyclophosphamide, etoposide, carboplatin, or ifosfamide. These advanced chemotherapy protocols are often used in higher-risk pediatric cancer treatment plans or in combination with radiation therapy and stem cell transplant for relapsed Wilms tumor.

​

Throughout chemotherapy treatment for childhood kidney cancer, pediatric oncology teams closely monitor treatment response, side effects of chemotherapy, infection risk, nutritional status, and overall health to balance effective cancer control with the child’s long-term growth, development, and survivorship needs.

Common Chemotherapy Drugs Used for Wilms Tumor

​

• Vincristine

• Dactinomycin

• Doxorubicin

• Cyclophosphamide

• Etoposide

• Carboplatin

• Ifosfamide

Side Effects of Chemotherapy

Chemotherapy for Wilms tumor targets rapidly growing cancer cells, but it can also temporarily affect healthy cells in the body. Because of this, many children receiving chemotherapy for pediatric kidney cancer experience side effects during treatment. The type and severity of chemotherapy side effects can vary depending on the medications used, the intensity of treatment, the stage of Wilms tumor, and the child’s overall health and immune status.

​

Common side effects of chemotherapy for childhood kidney cancer may include:

​

• Fatigue and low energy

• Nausea and vomiting

• Hair loss during chemotherapy

• Reduced appetite

• Mouth sores

• Increased infection risk due to lowered immunity

• Bruising or bleeding more easily

• Diarrhea or constipation

Children undergoing intensive chemotherapy for stage 4 Wilms tumor or relapsed Wilms tumor may sometimes require temporary hospitalization for fever, infections, dehydration, or treatment complications while their immune system is suppressed during therapy.

​

In some cases, chemotherapy treatment for Wilms tumor can also contribute to long-term or late effects following pediatric cancer treatment. Potential late effects of chemotherapy may involve the heart, kidneys, hearing, fertility, growth and development, or long-term survivorship health concerns. Because of this, children who have undergone chemotherapy for Wilms tumor often continue pediatric oncology follow-up care and survivorship monitoring long after treatment ends.

​

Throughout chemotherapy treatment for pediatric kidney cancer, pediatric oncology teams work closely with families to monitor treatment response, manage side effects of chemotherapy early, reduce infection risks, and provide supportive care to help children remain as comfortable, healthy, and supported as possible during treatment and recovery.

Chemotherapy for Relapsed Wilms Tumor

Chemotherapy for relapsed Wilms tumor is often more intensive than the treatment used during the initial diagnosis of childhood kidney cancer. When recurrent Wilms tumor returns after treatment, pediatric oncology teams may use different combinations of chemotherapy drugs designed to target cancer cells that may be more resistant to previous pediatric cancer therapies. Treatment for relapsed Wilms tumor is carefully tailored to improve cancer control while balancing long-term survivorship considerations and overall child health.

​

The specific chemotherapy treatment plan for recurrent Wilms tumor depends on several factors, including where the relapse occurs, how long the child remained in remission, the stage and histology of the disease, previous chemotherapy or radiation therapy received, and the child’s overall health and treatment tolerance. Children with high-risk Wilms tumor relapse or metastatic recurrent disease may require more aggressive pediatric oncology treatment protocols.

​

In some cases, high-dose chemotherapy for relapsed Wilms tumor may be combined with nephrectomy surgery, radiation therapy for recurrent Wilms tumor, or autologous stem cell transplant as part of a comprehensive pediatric relapse treatment strategy. These advanced treatment approaches are often used in children with stage 4 Wilms tumor recurrence or treatment-resistant pediatric kidney cancer.

​

Because relapse treatment for Wilms tumor is often physically and emotionally demanding, children undergoing intensive chemotherapy require close monitoring and supportive care throughout therapy. Pediatric oncology teams carefully monitor side effects of chemotherapy, infection risk, nutritional status, organ function, and overall recovery while helping families navigate the challenges of recurrent childhood cancer treatment and long-term survivorship care.